squiffy2
11-14-2008, 01:41 AM
http://www.msrc.co.uk/images/gallery/img_msbrain.jpg
British policies for treating Multiple Sclerosis patients put the country in the top quarter of a new 32-nation league table.
The MS "barometer" reveals wide discrepancies in treatment across Europe, with MS outpatient rehabilitation levels ranging from 100% of MS sufferers in the UK to just 1.5% in Hungary.
The annual survey by the European Multiple Sclerosis Platform (EMSP) also puts the percentage of MS patients receiving disease-modifying drugs at 90% in Luxembourg, 70% in Germany, 14% in the UK and just 2% in Poland.
The survey also looked at the ratio of neurologists to MS patients, time-limited MS treatments, the availability of specialist clinics and other treatment and follow-up care criteria to score points with a maximum possible of 270.
The 32-country average was 155, with the UK in eighth position with 192 points......................
For the full report please go to MSRC: Latest MS News (http://www.msrc.co.uk/index.cfm?fuseaction=show&pageid=1076)
British policies for treating Multiple Sclerosis patients put the country in the top quarter of a new 32-nation league table.
The MS "barometer" reveals wide discrepancies in treatment across Europe, with MS outpatient rehabilitation levels ranging from 100% of MS sufferers in the UK to just 1.5% in Hungary.
The annual survey by the European Multiple Sclerosis Platform (EMSP) also puts the percentage of MS patients receiving disease-modifying drugs at 90% in Luxembourg, 70% in Germany, 14% in the UK and just 2% in Poland.
The survey also looked at the ratio of neurologists to MS patients, time-limited MS treatments, the availability of specialist clinics and other treatment and follow-up care criteria to score points with a maximum possible of 270.
The 32-country average was 155, with the UK in eighth position with 192 points......................
For the full report please go to MSRC: Latest MS News (http://www.msrc.co.uk/index.cfm?fuseaction=show&pageid=1076)